Follow
Jan Zijlstra
Jan Zijlstra
Unknown affiliation
Verified email at planet.nl
Title
Cited by
Cited by
Year
A randomized trial of glutamine and antioxidants in critically ill patients
D Heyland, J Muscedere, PE Wischmeyer, D Cook, G Jones, M Albert, ...
New England Journal of Medicine 368 (16), 1489-1497, 2013
9642013
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line
JG Zijlstra, EGE de Vries, NH Mulder
Cancer Research 47 (7), 1780-1784, 1987
3151987
Leukocyte activation in sepsis; correlations with disease state and mortality
AC Muller Kobold, JE Tulleken, JG Zijlstra, W Sluiter, J Hermans, ...
Intensive care medicine 26 (7), 883-892, 2000
2562000
Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature
S Meijering, AM Corstjens, JE Tulleken, JHJM Meertens, JG Zijlstra, ...
Critical Care 10 (1), 1-7, 2006
2242006
Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
AM Corstjens, JJM Ligtenberg, ICC van der Horst, R Spanjersberg, ...
Critical Care 10 (5), 1-7, 2006
2012006
Quality of interhospital transport of critically ill patients: a prospective audit
JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ...
Critical Care 9 (4), 1-6, 2005
1952005
Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD
ML Duiverman, JB Wempe, G Bladder, DF Jansen, HAM Kerstjens, ...
Thorax 63 (12), 1052-1057, 2008
1902008
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
S de Jong, JG Zijlstra, EGE de Vries, NH Mulder
Cancer research 50 (2), 304-309, 1990
1801990
Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial
ML Duiverman, JB Wempe, G Bladder, JM Vonk, JG Zijlstra, ...
Respiratory research 12 (1), 1-10, 2011
1692011
Increased circulating endothelial progenitor cells in septic patients: correlation with survival
N Rafat, C Hanusch, PT Brinkkoetter, J Schulte, J Brade, JG Zijlstra, ...
Critical care medicine 35 (7), 1677-1684, 2007
1652007
Quality of interhospital transport of the critically ill: impact of a Mobile Intensive Care Unit with a specialized retrieval team
JS Wiegersma, JM Droogh, JG Zijlstra, J Fokkema, JJM Ligtenberg
Critical care 15 (1), 1-8, 2011
1642011
Organophosphorus pesticide poisoning: cases and developments
H Aardema, JH Meertens, JJ Ligtenberg, OM Peters-Polman, JE Tulleken, ...
Neth J Med 66 (4), 149-53, 2008
1642008
Blunted rise in platelet count in critically ill patients is associated with worse outcome
MWN Nijsten, HJ ten Duis, JG Zijlstra, RJ Porte, JH Zwaveling, JC Paling
Critical care medicine 28 (12), 3843-3846, 2000
1642000
Transferring the critically ill patient: are we there yet?
JM Droogh, M Smit, AR Absalom, JJM Ligtenberg, JG Zijlstra
Critical Care 19 (1), 1-7, 2015
1632015
Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria
J Koeze, F Keus, W Dieperink, ICC Van der Horst, JG Zijlstra, ...
BMC nephrology 18 (1), 1-9, 2017
1622017
Bench-to-bedside review: Angiopoietin signalling in critical illness–a future target?
M van Meurs, P Kümpers, JJM Ligtenberg, JHJM Meertens, G Molema, ...
Critical care 13 (2), 1-13, 2009
1572009
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide …
AGJ van der Zee, H Hollema, S de Jong, H Boonstra, A Gouw, ...
Cancer research 51 (21), 5915-5920, 1991
1451991
Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis
M Volbeda, J Wetterslev, C Gluud, JG Zijlstra, ICC van der Horst, F Keus
Intensive care medicine 41 (7), 1220-1234, 2015
1392015
Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers
JW Fijen, JG Zijlstra, P De Boer, R Spanjersberg, JW Cohen Tervaert, ...
Clinical & Experimental Immunology 124 (1), 16-20, 2001
1342001
Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis
P Kümpers, M van Meurs, S David, G Molema, J Bijzet, A Lukasz, F Biertz, ...
Critical care 13 (3), 1-9, 2009
1182009
The system can't perform the operation now. Try again later.
Articles 1–20